Podcast by Michelle Ghilotti Mandel and Josh Mandel
…
continue reading
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's. 🎧 Stay in the Loop! For the latest news and updates, visit our website: https://vial.com Follow us on social media for real-time insights: Twitter: https://twitter.com/VialTrials LinkedIn: https://www.linkedin.com/company/vialtrials
…
continue reading
Mo Mandel (Chelsea Lately, Comedy Knockout, CONAN) goes through the most challenging and divisive issues of the day with a rotating pool of guests. He also complains a lot about his own life.
…
continue reading
This is the official PodCast of the Big Box PC Game Collectors group. We are a group who focuses on PC game collecting, and we cover all personal computers including the Apple II, Commodore, TRS-80. We're not limited to vintage PC games; we even cover modern big box PC releases.
…
continue reading
A podcast discussing backlist gems and the Spanish writer Javier Marías, late the King of Redonda. In Season 2 we read the novels of Muriel Spark. From Lori Feathers and Tom Flynn.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 27: "I Hotel" by Karen Tei Yamashita, w/ special guest Josh Cook
1:01:25
1:01:25
Play later
Play later
Lists
Like
Liked
1:01:25
We’re joined today by Josh Cook. Josh is a bookseller and co-owner at Porter Square Books in Cambridge, Massachusetts, where he has worked since 2004. He is the author of the critically acclaimed postmodern detective novel An Exaggerated Murder and most recently of The Art of Libromancy: Selling Books and Reading Books in the Twenty-First Century, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 62: Josh Mandel-Brehm - CEO, CAMP4 Therapeutics
20:10
20:10
Play later
Play later
Lists
Like
Liked
20:10
Explore the untapped potential of RNA amplifying therapeutics with the CEO of CAMP4 Therapeutics, Josh Mandel-Brehm. We uncover the power of antisense oligonucleotides in rewriting the narrative for genetic diseases characterized by protein deficiency. Josh takes us behind the scenes of their innovative RNA Actuating Platform (RAP), a map charting …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 61: William Korinek - CEO and Co-Founder, Astrocyte Pharmaceuticals
24:20
24:20
Play later
Play later
Lists
Like
Liked
24:20
Embark on a journey through the neurons and synapses of brain science with William Korinek, the CEO of Astrocyte Pharmaceuticals. In a conversation that fuses the molecular intricacies of neuroprotection with the humanistic pursuit of medical advancement, Bill reveals his unique path from molecular biologist to biotech innovator. Together, we unrav…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 26: "Wild Milk: Stories" by Sabrina Orah Mark, w/ special guest Lara Ehrlich
55:27
55:27
Play later
Play later
Lists
Like
Liked
55:27
We’re joined today by Lara Ehrlich, a writer, editor, and longtime friend (she and Tom go back 20 years, which seems impossible). Her first story collection, Animal Wife, was published by Red Hen Press back in 2020, and her first novel, Bind Me Tighter Still, will publish in 2025, also from Red Hen. She also hosts a conversation series, Writer Moth…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 60: Rachel Haines - VP of Clinical Development & Operations, Rinri Therapeutics
18:30
18:30
Play later
Play later
Lists
Like
Liked
18:30
By Vial
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 59: Bas van der Baan - President & CEO, Lixte Biotechnology
17:32
17:32
Play later
Play later
Lists
Like
Liked
17:32
Join as we dive deep into the world of oncology drug development with Bas van der Baan of Lixte. Discover the inspiration behind Lixte's focus on PP2A inhibitors and how this innovative approach is poised to revolutionize cancer treatment by enhancing chemotherapy and immunotherapy responses. Bas shares insights into ongoing clinical trials, regula…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 25: "Austerlitz" by W.G. Sebald, translated by Anthea Bell, w/ special guest Mark Haber
56:32
56:32
Play later
Play later
Lists
Like
Liked
56:32
We’re joined today by Mark Haber of Coffee House Press (formerly of Brazos Bookstore in Houston). Mark is the author of two novels, Reinhardt’s Garden and Saint Sebastian’s Abyss, and the forthcoming novel Lesser Ruins, as well as a forthcoming novella, Ada. We chat about his work as well as Austerlitz by W.G. Sebald, translated by Anthea Bell. A q…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 58: Samarendra Mohanty - President & CSO, Nanoscope Therapeutics
16:36
16:36
Play later
Play later
Lists
Like
Liked
16:36
Dr. Samar Mohanty, president and CSO of Nanoscope Therapeutics joins us to shed light on the revolutionary gene therapy that's giving hope to individuals with retinal degenerative diseases by pioneering a treatment that can re-sensitize the retina to detect low light levels. We open the curtains on their groundbreaking multi-characteristic opsins (…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 24: "The Tanners" by Robert Walser, translated by Susan Bernofsky, w/ special guest Spencer Ruchti
1:04:00
1:04:00
Play later
Play later
Lists
Like
Liked
1:04:00
Today Spencer Ruchti of Third Place Books joins to chat about The Tanners by Robert Walser, translated by Susan Bernofsky. We actually recorded this back in November and are glad to get it out into the world. Early on Spencer dips out momentarily due to an alarm in the store, but all ended up being right with the world. At least in that instant. Th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 57: Rob Etherington- CEO and President at Clene Nanomedicine
20:06
20:06
Play later
Play later
Lists
Like
Liked
20:06
Imagine unlocking the secrets to revitalizing the brain's energy centers and turning the tide on neurodegenerative diseases. In this episode, Rob introduces us to CNM-Au8, an oral nanotherapeutic with the potential to recharge failing mitochondria. Our discussion traverses the innovative path Clene has charted, from the drug's conception to the exc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 23: "Being Here is Everything" by Marie Darrieussecq, translated by Penny Hueston, w/ special guest Tara Cheesman
1:02:28
1:02:28
Play later
Play later
Lists
Like
Liked
1:02:28
Kicking off 2024 we welcome Tara Cheesman to the podcast with her recommendation, Being Here Is Everything: The Life and Times of Paula Modersohn-Becker by Marie Darriussecq, translated by Penny Hueston. Tara is a freelance critic, former judge of the Best Translated Book Award, and she brings us our first work of nonfiction. We have an absolutely …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 56: Jason Bock- Founder and CEO at CTMC
22:28
22:28
Play later
Play later
Lists
Like
Liked
22:28
Step into the future as Dr. Jason Bock, founder and CEO of CTMC discusses the company's unique approach to accelerating cell therapies from development to testing, and the power of collaboration in reshaping the future of cancer treatment. Listen in as we discuss how CTMC's partnership with MD Anderson is not just technical but deeply human in natu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 55: Alex Federation- Co-Founder at Talus Bio
15:27
15:27
Play later
Play later
Lists
Like
Liked
15:27
Embark on a quest to unravel the 'undruggable' genome with Alex Federation, Co-founder of Talus Bio. Explore challenges in targeting transcription factors in cancer with Talus's innovative Marmot platform. Discover potential breakthroughs in rare diseases and pediatric cancers, and glimpse into the future of studying transcription factors within li…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 54: Ahmed Hamdy- CEO at Vincerx Pharma
16:52
16:52
Play later
Play later
Lists
Like
Liked
16:52
Join Dr. Ahmed Hamdy, CEO of Vincerx Pharma, on a compelling journey through oncology. From co-founding Acerta Pharma to pioneering patient-centric innovations, Dr. Hamdy shares his impactful career. Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical ex…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 53: Sam Clark- CEO & Founder at Terran Biosciences
18:10
18:10
Play later
Play later
Lists
Like
Liked
18:10
Have you ever considered the untapped potential of abandoned drugs? Join Dr. Sam Clark to discuss how his personal drive to combat mental illness is leading to breakthroughs in treatments for neurological and psychiatric diseases. Witness how Terran is not only resurrecting discarded medications for new purposes, but also pioneering the next genera…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 52: Mark McDonough- President & CEO of ChromaCode
16:54
16:54
Play later
Play later
Lists
Like
Liked
16:54
Ever wondered how technology could drastically improve early detection in healthcare? Let us take you on a journey with Mark McDonough, President and CEO of ChromaCode, as we unfold the world of molecular diagnostics with a special focus on HDPCR technology. Mark, with his diverse background in the military and healthcare, brings a fresh perspectiv…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 51: Bogdan Knezevic - Co-founder & CEO at Kaleidoscope.bio
21:16
21:16
Play later
Play later
Lists
Like
Liked
21:16
Embark on a journey through the intricate world of biotech with Bogdan Kezevic, co-founder and CEO of Kaleidoscope Bio, and uncover the revolutionary software shaping the future of scientific research. Bogdan's leap from scientist to entrepreneur has led to groundbreaking solutions for the challenges plaguing biotech. In our chat, he shares how dat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 50: Steven Reed - Co-Founder & CEO at HDT Bio
12:19
12:19
Play later
Play later
Lists
Like
Liked
12:19
What does it take to revolutionize the world of vaccines and touch lives across the globe? Join us on a riveting journey with Steven Reed, CEO and co-founder of HDT-Bio, as we explore the creation of the first refined tuberculosis vaccine and dive into the remarkable strides in RNA technology. This episode lifts the veil on the science that could r…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 22: "The Prime of Miss Jean Brodie" by Muriel Spark
1:06:11
1:06:11
Play later
Play later
Lists
Like
Liked
1:06:11
The Prime of Miss Jean Brodie is upon us and it does not disappoint. Too much to say about this one and, as always, we could have gone an hour longer and still not covered it all. An absolutely fantastic novel and one that certainly lives up to the hype and praise that surrounds it. Titles/authors mentioned: The Secret History by Donna Tartt O Cale…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 21: "The Bachelors" by Muriel Spark
57:17
57:17
Play later
Play later
Lists
Like
Liked
57:17
We stand on the precipice, one episode away from THE PRIME! Before that, though, we discuss The Bachelors, a fantastic novel chock full of some of the strangest characters Spark has written, which is really saying something. Mediums, epileptics, blackmail, criminality, and much, much more abound in this one. And one of the funniest scenes yet invol…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 49: Jeffrey Bacha - Chairman, Rakovina Therapeutics
21:45
21:45
Play later
Play later
Lists
Like
Liked
21:45
Join Jeffrey Bacha, a pioneer in the fight against cancer and the creative force behind Rakovina Therapeutics. For 25 years, Jeffrey has been reshaping the industry landscape, and today, he gives us a peek into his world of innovation. We venture into Rakovina's research and development of oncology drugs. exploring their groundbreaking technique co…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 20: "The Ballad of Peckham Rye" by Muriel Spark
51:47
51:47
Play later
Play later
Lists
Like
Liked
51:47
We’re edging closer to THE PRIME, but today we chat about The Ballad of Peckham Rye. Spark’s novels are incredibly fun, but this might be the wildest, featuring an incredible character name (Dougal Douglas), a lot of absenteeism, a textile factory, a Nun Tunnel, and dancing. Lots of dancing. Click here to subscribe to our Substack and find us on th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 48: Jonathan Thon - Founder & CEO at STRM.BIO
21:52
21:52
Play later
Play later
Lists
Like
Liked
21:52
Embark on a fascinating exploration of biotech entrepreneurship, guided by an expert who's been in the trenches: Jonathan Thon, CEO and founder of STRM.BIO. We'll give you an insider's view of his journey from academia to the cutting edge of biotech, unveiling his trailblazing work on platelet production and the transformative potential of extracel…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 47: Oscar Segurado- CMO at ASC Therapeutics
22:00
22:00
Play later
Play later
Lists
Like
Liked
22:00
Ever wondered how far we've truly come in the realm of gene and cell therapies, and where we're headed next? This captivating conversation with Oscar Segurado, the CMO of ASC Therapeutics, will satisfy your curiosity. Oscar, a veteran in the biopharmaceutical industry, shares fascinating insights on ASC Therapeutics' groundbreaking innovation in pe…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 19: "Tell Them of Battles, Kings, and Elephants" by Mathias Énard, translated by Charlotte Mandell
53:03
53:03
Play later
Play later
Lists
Like
Liked
53:03
This week we discuss Tell Them of Battles, Kings, and Elephants, an absolutely wonderful gem of a novel from French author Mathias Énard, translated by Charlotte Mandell. In 150ish pages Énard recreates the Constantinople of the early 16th Century and the brief time Michelangelo resided there to build a grand bridge. If you’ve not read Énard before…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episodes 46: Spiro Rombotis- CEO at Cyclacel
21:28
21:28
Play later
Play later
Lists
Like
Liked
21:28
We’re thrilled to share our enlightening exchange with Spiro Rombotis, the seasoned CEO of Cyclacel. He peels back the curtain on the breakthrough discovery of B53, a commonly mutated gene in cancer patients, and the inspiring success of FADRA, their lead drug in clinical trials. Furthermore, Spiro delves into the highs and lows faced by Cyclacel, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 18: "Memento Mori" by Muriel Spark
56:07
56:07
Play later
Play later
Lists
Like
Liked
56:07
This week we discuss Memento Mori, Spark’s third novel and, as we’ve come to expect, it’s a really fun ride. This go-round she brings us into the lives of septuagenarians and octogenarians as they fume, backbite, explore their sexual proclivities, and all come to terms (or not) with their impending deaths. And, of course, it’s very, very funny. Cli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 17: "Ceremony" by Leslie Marmon Silko w/ special guest Robin McLean
1:04:53
1:04:53
Play later
Play later
Lists
Like
Liked
1:04:53
Episode 5 of Season 2: we get to chat with Robin McLean about Ceremony by Leslie Marion Silko. And, yeah, this is probably our best episode so far, which isn’t shocking because we’re talking about talking with Robin McLean. So, all that aside, it’s a great conversation and one that could have gone on for hours and hours yet. We could have gone deep…
…
continue reading
In Episode 4 of Season 2 we dig into Muriel Spark’s sophomore effort, Robinson. Gotta say: it’s incredible and we couldn’t be more excited to keep on keeping on with her work. This time around we trade London (mostly) for a lonely island in the Atlantic and a story that is funny, tense, clever, whimsical, and just an all-around masterclass in write…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 45: Frank Borriello- Founder and CEO at Alloplex Biotherapeutics
17:56
17:56
Play later
Play later
Lists
Like
Liked
17:56
Ever wondered about the people who are leading the fight against cancer, developing groundbreaking treatments, and changing lives? Meet Frank Boriello, the mind behind SUPLEXA cell therapy, and the CEO and founder of Alloplex Biotherapeutics. In our conversation, Frank shares the personal backstory that sparked his quest to revolutionize cancer tre…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 15: "The Conqueror" by Jan Kjærstad, translated by Barbara Haveland w/ special guest Chad Post
1:12:45
1:12:45
Play later
Play later
Lists
Like
Liked
1:12:45
Having sorted some annoying technical issues, herewith Episode 3 of Season 2 (our way of apologizing for the delay in uploading this episode) in which we discuss The Conqueror by Jan Kjærstad, translated by Barbara Haveland and published by Open Letter Books. And to kick off our series of guest hosts, Chad Post of Open Letter Books (and Dalkey Arch…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 44: Max Darnell- CEO & Co-Founder at Modulus Therapeutics
14:18
14:18
Play later
Play later
Lists
Like
Liked
14:18
Max Darnell, CEO and co-founder of Modulus Therapeutics, takes us through his thrilling journey from bioengineering and systems biology to launching a biotech startup. Max unveils how his team's curiosity and motivation, along with their high throughput discovery platform, are revolutionizing cell and cell therapy component designs. Hear how Modulu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 14: "The Comforters" by Muriel Spark
1:04:27
1:04:27
Play later
Play later
Lists
Like
Liked
1:04:27
We kick off our season-long read of Muriel Spark's novels this week and what a start! The Comforters is Spark's debut, published in 1956, and is, quite simply, magnificent. Lori and Tom wax heavily on how impressive this novel is and how incredibly fun it is, too! It's going to be quite a great season judging by this title alone. Click here to subs…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 43: Pepper Landson- Co-Founder & CEO of Praetego
19:03
19:03
Play later
Play later
Lists
Like
Liked
19:03
Join 30-year industry veteran Pepper Landson, Co-founder and CEO of Praetego as she shares her inspiring journey that led her to tackle Alzheimer's and dementia through the innovative use of amadorins. Pepper's intriguing narrative not only highlights her commitment to the public health crisis surrounding these neurodegenerative diseases, but also …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 13: "Chronicle of the Murdered House" by Lucio Cardoso, translated by Margaret Jull Costa and Robin Patterson
1:13:26
1:13:26
Play later
Play later
Lists
Like
Liked
1:13:26
And we’re back! Welcome to Season Two of Lost in Redonda. We kick things off with a backlist conversation on Chronicle of the Murdered House by Lucio Cardoso, translated by Margaret Jull Costa and Robin Patterson, published by Open Letter Books. It’s probably one of the fastest moving 600 page sagas of a Brazilian family you’re likely to encounter.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 42: Dr. Timothy Miller - Co-Founder, President, & CEO at Forge Biologics
12:34
12:34
Play later
Play later
Lists
Like
Liked
12:34
Ever wonder how the complexities of gene therapies are addressed from bench to bedside? The creative solutions lie within the innovative approaches of seasoned professionals like Dr. Timothy Miller, Co-Founder, President, & CEO at Forge Biologics. With a fascinating career that interlaces academia, biotech, and entrepreneurship, Dr. Miller brings a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 41: David Esposito - President and CEO at ONL Therapeutics
19:35
19:35
Play later
Play later
Lists
Like
Liked
19:35
What if your vision could be saved by the precise application of innovative biotech? Join us as we talk to David Esposito, President & CEO of ONL Therapeutics, and delve deep into his take on leadership. He shares how his military background has been instrumental in the successful management of clinical trials, particularly when navigating the unpr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 40: Alfredo Andere - Co-Founder & CEO at LatchBio
24:41
24:41
Play later
Play later
Lists
Like
Liked
24:41
Does the convergence of tech and biology hold the key to reshaping biotech's data infrastructure? Our recent chat with Alfredo Andere, Co-Founder and CEO at LatchBio, certainly supports this notion. This episode offers a deep dive into Alfredo's journey from being part of the Google Brain team to co-founding Latch Bio - a company that is making wav…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 12: "Your Face Tomorrow, Volume Three: Poison, Shadow, and Farewell"
1:24:59
1:24:59
Play later
Play later
Lists
Like
Liked
1:24:59
Here it is, folks, our final episode on Your Face Tomorrow and the last part of our Marías project. It's a longer one, but very worth it if we do say so ourselves. Our next season and new project will kick off in a couple weeks' time, but before that a thank you for listening along. It's a fun project and one we hope folks are getting as much out o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 39: Lucas Siow - CEO & Co-Founder at ProteinQure
15:05
15:05
Play later
Play later
Lists
Like
Liked
15:05
Embark on a journey into the forefront of biotech with Lucas Siow, the visionary behind ProteinQure, as he unveils the impact of his computational platform on peptide therapeutics and delves into the art of team building. Explore the fusion of medicinal chemistry and high throughput screens, discover the essence of benchmarking in drug discovery, a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 11: "Your Face Tomorrow, Volume Two: Dance and Dream"
55:05
55:05
Play later
Play later
Lists
Like
Liked
55:05
It's very strange to be this close to the end of our Marías focus, but that's rather how time moves, ever forward (unless you're Marías and can make time a rather fungible thing in your novels...). This is a fun episode, touching on East End gangsters, Spandau Ballet, the Spanish Civil War, swordplay, and more. And a couple of characters from the p…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 10: "Your Face Tomorrow, Volume 1: Fever and Spear"
1:01:57
1:01:57
Play later
Play later
Lists
Like
Liked
1:01:57
And now we enter the homestretch. Over the next few episodes we'll tackle Marías' masterpiece, Your Face Tomorrow. Starting, of course, with the first volume, Fever and Spear. Once we wrap up the Marías project we're going to take a week or so off and then we'll be back with more backlist dives and a new author whose work we'll spend some time digg…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 9: "Imperium" by Christian Kracht, translated by Daniel Bowles
1:18:17
1:18:17
Play later
Play later
Lists
Like
Liked
1:18:17
This week we dive into Christian Kracht's Imperium, and boy do we ever go deep (sorry/not sorry). It's an incredible piece of historical fiction (one of Tom's favorites and, now, one of Lori's) that follows one man's attempts to manifest his destiny to live in the tropics and subsist only on the noble coconut. And walk around nude. In the German So…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 8: "The Infatuations" and "The Man Of Feeling"
58:44
58:44
Play later
Play later
Lists
Like
Liked
58:44
A fun discussion this week of two novels published almost 30 years apart in The Infatuations and The Man of Feeling. We walk down some interesting paths and may get ourselves into a moral quandary or two (wouldn't be a discussion of Marías without some moral murkiness, now would it?). These are the last two Marías novels we discuss before wrapping …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 7: "My Heart Hemmed In" by Marie NDiaye, translated by Jordan Stump
1:05:16
1:05:16
Play later
Play later
Lists
Like
Liked
1:05:16
We're going weekly! As the episodes have grown longer we've decided to split them up so instead of discussing two titles per episode (and delivering a 2+ hour podcast) every other week we're switching to one title every week. A guide to the next few episodes will be up on the Substack shortly. This week we dig into Marie NDiaye's My Heart Hemmed In…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 6: backlist spotlight: "Gob's Grief" by Chris Adrian; "Thus Bad Begins"
2:26:40
2:26:40
Play later
Play later
Lists
Like
Liked
2:26:40
In our sixth episode we discuss Gob’s Grief by Chris Adrian for our backlist deep dive. In the Marías portion we dig into Thus Bad Begins (spoiler alert: it’s phenomenal). This is a doozy of an episode, so stay hydrated and do be a hero: listen to the whole 2+ hours in one go! Books mentioned in this episode: Names on the Land: A Historical Account…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 38: Stephen Doyle - Chief Business Officer at ASLAN Pharmaceuticals
21:38
21:38
Play later
Play later
Lists
Like
Liked
21:38
For episode 38, we sit down with Stephen Doyle, Chief Business Officer at ASLAN Pharmaceuticals. Find out more about the challenges involved in developing innovative treatments and how ASLAN is addressing those difficulties as they work to bring new therapies like their novel atopic dermatitis treatment to the market. First In Human is a biotech-fo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 37: David Bearss, Ph.D. - President and CEO of Halia Therapeutics
20:23
20:23
Play later
Play later
Lists
Like
Liked
20:23
For episode 37, we connect with David Bearss, President and CEO of Halia Therapeutics. Learn more about the connection between chronic inflammation and disease, and how Halia is using their novel therapies to treat both inflammatory disorders and neurological diseases. First In Human is a biotech-focused podcast that interviews industry leaders and…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 5: an ending in the middle, "Tomas Nevinson"
1:16:58
1:16:58
Play later
Play later
Lists
Like
Liked
1:16:58
Lori and Tom discuss Marías' final novel, Tomás Nevinson, just published in the US on May 23rd. A warning that spoilers do occur, especially after the 37 minute mark, so listener beware. Next episode we will return to discussing backlist in addition to our Marías deep-dives. Click here to subscribe to our Substack and do follow us on the socials, @…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 36: Romain Micol - CEO & Co-Founder at Combined Therapeutics
11:29
11:29
Play later
Play later
Lists
Like
Liked
11:29
For Episode 36, we chat with Romain Micol, CEO & Co-Founder of Combined Therapeutics. Stay tuned to learn how Combined Therapeutics is developing unique mRNA-based treatments to better protect the world from infectious disease and cancer. First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their…
…
continue reading